[First clinical trails with the "medium tranquilizer" mesoridazine].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D010640:Phenothiazines; D010919:Placebos; D014149:Tranquilizing Agents
Erste klinische Erfahrungen mit dem "Medium Tranquilizer" Mesoridazin.